How to Decode Market Access in Canada: Are There Essential Tips for Success, Tara Cowling and Jody Filkowski?

In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape. Discover how AI is revolutionizing market research, streamlining dossier preparation, and reshaping pricing strategies. This episode is for anyone who wants to dive deep into how the potential of AI in enhancing market research through emotion recognition and data analysis can significantly impact payer research and training for sales reps. Imagine having comprehensive dossiers at your fingertips in the future, reducing preparation time from months to seconds.Listen now to explore how AI is set to redefine market access, driving efficiency and innovation in ways we've only begun to imagine. Stay ahead of the curve and join the conversation on how AI will shape our industry's future!Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#MarketAccess #AI #HealthcareInnovation #HealthcareSystem #marketaccess #marketaccesspodcast 

What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond.In this episode you will learn how AI mirrors the industrial revolution and how that results in both unique opportunities and challenges. Aleksey also illustrates some real-world applications of AI in market access, from predictive analytics in drug pricing to automated literature reviews and more. The discussion also goes further into the importance of privacy and ethical considerations that follows AI use, and why it is necessary to ensure data security while maximizing the benefits of technologyWhether you're an industry professional or a tech enthusiast, this episode offers a comprehensive overview of AI's current applications and its potential to drive future innovations in healthcare.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#ArtificialIntelligence #AIInsights #HealthcareInnovation #Medtech #MarketAccess #HealthcareSystem #MedicalTechnology #marketaccess #marketaccesspodcast #medtech

In the newest episode of MAP - the Market Access podcast, experts Tara Cowling and Jody Filkowski unpacks the complexities and nuances of Canada's market access for pharmaceuticals and medical devices. From regulatory hurdles to intricate reimbursement pathways, they shed light on what it takes to successfully navigate this diverse and challenging landscape.Whether you're dealing with drugs or medical devices, understanding the distinct processes in Canada, including the differences between provinces and the role of private versus public payers, is crucial. This episode offers a deep dive into the practical strategies and real-world challenges faced by industry professionals working within the Canadian healthcare system. They also share insights about the emerging role of digital health in Canada, and the potential changes with the introduction of the Canadian Drug Agency.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #Canada #Healthcare #marketaccess #marketaccesspodcast #medtech #pharmaceuticals #medicaldevices #digitalhealth

What role will AI & VR transformations play in the future? Tune in to this fascinating episode of the Market Access Podcast to hear as our special guest, Glib Kutepov, CEO and founder of Modulate, shares his expertise. Glib uncovers the potential of generative AI and neural networks in revolutionizing market access strategies and highlights the challenges and solutions around data privacy as well as the integration of private layers to protect sensitive information. He also touches on the role of VR in empathizing with patients' experiences, adding a deeply human element to the data-driven world of market access. This episode will not only provide a deeper understanding for the technology, but also tools of practical ways to implement it.AI and VR could change the data driven health care in the future, as it can benefit the strategic work as well as assist in ensuring a better understanding for the patients’ experiences. Whether you're a healthcare professional, market access manager, or tech enthusiast, this conversation offers a glimpse into a future where technology enhances our approach to healthcare on multiple levels.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#HealthcareInnovation #MarketAccess #marketaccesspodcast #ArtificialIntelligence #VirtualReality #FutureOfHealthcare #marketaccess

Tune into a brand new episode of the Market Access Podcast to listen to an intriguing conversation about the Italian healthcare system with Giacomo Matteo Bruno and Dr Stefan Walzer. Together they explore the balance between innovation, sustainability, and patient access in the heart of Europe. Discover the evolution, challenges, and future of healthcare in Italy, from the foundational principles laid down in 1978 to the dynamic, ever-evolving landscape of today.Giacomo shares his insights on how to navigate the crucial role of health economics in drug pathways as well as giving a birds-eye perspective over the healthcare system in Italy today and the challenges that comes with an aging population and rising chronic diseases. Giacomo presents a vision for embracing innovation while maintaining the system’s integrity. If you are searching for deeper knowledge about the Italian healthcare system and learn about strategies on how to enter the Italian market, this episode is for you. Learn about the regional nuances that make Italy unique, the steps for drug reimbursement, and the importance of targeted therapies in personalized medicine. Giacomo also sheds light on the pioneering electronic dossier system introduced by IFA, streamlining the approval process and setting a new standard in healthcare innovation.Whether you're a healthcare professional, a pharmaceutical company, or just intrigued by the global healthcare landscape, this conversation offers valuable lessons and strategies for success in one of the world's most revered healthcare systems. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#HealthcareInnovation #MarketAccess #Italy #ItalianHealthcare #PharmaceuticalIndustry #marketaccesspodcast #marketaccess

In this captivating episode of MAP, the Market Access Podcast, we welcome Aymeric Chaupin, a seasoned expert in pricing and market access. Aymeric's unique perspective, shaped by his deep understanding of both the American and European healthcare systems, sheds light on the complexities of healthcare reimbursement pathways in the US and their impact on the delivery of health services.Join us as Aymeric unveils the challenges and opportunities within the US healthcare market. He emphasizes the importance of coding and understanding reimbursement pathways for effective market access and explores the broader implications for patient care and the healthcare system as a whole.This episode is a treasure trove of insights for startups and companies looking to navigate the US healthcare landscape. Aymeric shares practical advice on entering the market, from partnering with pharmaceutical giants to engaging with the FDA early in the clinical trial process. He stresses the necessity of having a clear strategy and representation in the US to negotiate coverage and formulary placement, ensuring commercial success in this pivotal market.Despite the hurdles, the US remains a key player in the global pharmaceutical and medical device industry, accounting for a significant portion of global revenue.Tune in for an enlightening discussion that navigates the intricacies of the US healthcare system, providing valuable lessons and strategies for companies aspiring to make their mark in this challenging yet rewarding market.#HealthcareInnovation #MarketAccess #US #USHealthcareSystem #PharmaceuticalIndustry #MedicalDevices #HealthcareReform #marketaccess #marketaccesspodcast

Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights on making impactful career transitions. Market Access veteran Dr. Stefan Walzer and Dipti Tankala also talk about the significance of networking, mentorship, and the essential skills for success. This episode is a must-listen for professionals looking to navigate the complex world of market access and leverage opportunities in the pharmaceutical field. Tune in to unlock your career potential with expert advice from a seasoned market access professional. Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #Canada #HealthcareSystem #marketaccess #marketaccesspodcast #medtech

In this essential episode of the Market Access Podcast, we're diving deep into the critical aspects of commercializing healthcare innovations in the US market. Whether you're in medtech, pharma, biotech, or health tech, understanding the US healthcare landscape is key to your product's success. Join us as Dr. Stefan Walzer and Paul-Lukas Hoffschmidt, CEO of Alpha Sophia (www.alphasophia.com), share their wealth of knowledge on effective strategies for navigating this complex terrain.Key Topics Covered:Understanding US Market Access: An overview of the unique challenges and opportunities in the US healthcare system for new entrants.Role of Healthcare Professionals: Insight into how healthcare professionals influence market access and product uptake.Data-Driven Strategies: The importance of leveraging data in targeting and positioning your product effectively.Commercialization Pathways: Expert advice on navigating regulatory, reimbursement, and distribution challenges.Case Studies: Real-world examples of successful market entry and the lessons learned.Future Trends: Predictions on how the US market access landscape may evolve and what it means for healthcare innovators.Why You Should Listen:Gain Expert Insights: Learn from leading experts with firsthand experience in the US healthcare market.Strategic Advice: Receive actionable advice on overcoming the hurdles to market entry and expansion.Stay Ahead: Understand the latest trends and how they impact market access strategies.This episode is indispensable for CEOs, entrepreneurs, market access professionals, and anyone involved in the commercialization of healthcare innovations looking to penetrate or expand their presence in the US market.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #US #HealthcareSystem #MarketAccessPodcast

Join us for a fascinating dive into the complexities of French market access with our latest episode of the Map Podcast. Dr. Stefan Walzer, health economist and founder of Mars Market Access & Pricing Strategy, engages with Dr. Benoit Salaun, a seasoned expert in French healthcare reimbursement.They unravel:The nuances of the French healthcare systemThe essentials of medical device reimbursementThe importance of demonstrating efficacy, safety, and affordabilityThe role of clinical evidence and the adaptability of international data to French contextsThe strategic considerations for medtech companies entering the French marketWhether you’re a healthcare professional, a medtech innovator, or a market access strategist, this episode is packed with insights on how to ensure your medical device not only enters the French market but also achieves the price it deserves.Tune in to gain expert knowledge on creating a successful roadmap for market access in France, and discover if the "French way" aligns with your company's goals.🎧 Listen now and elevate your market access strategy! Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de#Medtech #MarketAccess #HealthcareInnovation #FrenchHealthcareSystem #marketaccess #marketaccesspodcast

In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement including the famous article 71, which allows an early paid access.Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate.In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP PodcastsMAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de